{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:01:52Z","timestamp":1794024112234,"version":"4.8.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ebiom.2024.105153","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T21:08:57Z","timestamp":1716844137000},"page":"105153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-1016","authenticated-orcid":false,"given":"Carly M.","family":"Bliss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffael","family":"Nachbagauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mariottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Feser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdi","family":"Naficy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Guptill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel B.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Berlanda-Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Innis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-6560","authenticated-orcid":false,"given":"Lynda","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib1","article-title":"Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR Project","volume":"9","author":"Paget","year":"2019","journal-title":"J\u00a0Glob Health"},{"issue":"3578","key":"10.1016\/j.ebiom.2024.105153_bib2","article-title":"Adenoviral vectors as vaccines for emerging avian influenza viruses","volume":"11","author":"Kerstetter","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105153_bib3","first-page":"267","article-title":"We need to keep an eye on avian influenza","volume":"23","author":"Krammer","year":"2023","journal-title":"Nat Rev"},{"issue":"47","key":"10.1016\/j.ebiom.2024.105153_bib4","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105153_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006682","article-title":"A\u00a0structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine","volume":"13","author":"Wu","year":"2017","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105153_bib6","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.5.18-00035","article-title":"Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017\/18 vaccine effectiveness, Canada, January 2018","volume":"23","author":"Skowronski","year":"2018","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.chom.2018.06.016","article-title":"Overcoming barriers in the path to a universal influenza virus vaccine","volume":"24","author":"Coughlan","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/vaccines6020018","article-title":"Harnessing the power of T cells: the promising hope for a universal influenza vaccine","volume":"6","author":"Clemens","year":"2018","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105153_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008965.pub3","article-title":"Vaccines for preventing influenza in healthy children","volume":"2012","author":"Jefferson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105153_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001269.pub4","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2225645","article-title":"Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses","volume":"12","author":"Fereidouni","year":"2023","journal-title":"Emerg Microb Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A\u00a0chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","article-title":"Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Bernstein","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105153_bib15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S1473-3099(22)00024-X","article-title":"Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial","volume":"22","author":"Folschweiller","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105153_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.ebiom.2024.105153_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2018.02.011","article-title":"Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults","volume":"29","author":"Coughlan","year":"2018","journal-title":"EBioMedicine"},{"issue":"46\u201347","key":"10.1016\/j.ebiom.2024.105153_bib18","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105153_bib19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3201\/eid0805.010476","article-title":"DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice","volume":"8","author":"Epstein","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105153_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41591-021-01660-8","article-title":"Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial","volume":"28","author":"Houser","year":"2022","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105153_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/v8060155","article-title":"Accurate measurement of the effects of all amino-acid mutations on influenza hemagglutinin","volume":"8","author":"Doud","year":"2016","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib23","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-018-03665-3","article-title":"How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin","volume":"9","author":"Doud","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28706-1","article-title":"The influenza virus hemagglutinin head evolves faster than the stalk domain","volume":"8","author":"Kirkpatrick","year":"2018","journal-title":"Sci Rep"},{"issue":"6497","key":"10.1016\/j.ebiom.2024.105153_bib25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.aaz5143","article-title":"Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2024.105153_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A\u00a0universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105153_bib27","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A\u00a0multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.ebiom.2024.105153_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A\u00a0chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccines"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105153_bib29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in\u00a0vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in\u00a0vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat Med"},{"issue":"7456","key":"10.1016\/j.ebiom.2024.105153_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105153_bib33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","article-title":"Novel correlates of protection against pandemic H1N1 influenza A virus infection","volume":"25","author":"Ng","year":"2019","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105153_bib34","article-title":"Pre-existing hemagglutinin stalk antibodies correlate with protection of lower respiratory symptoms in flu-infected transplant patients","volume":"1","author":"Aydillo","year":"2020","journal-title":"Cell Rep Med"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105153_bib35","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ymthe.2022.01.011","article-title":"A\u00a0single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice","volume":"30","author":"Bliss","year":"2022","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02810-18","article-title":"Design of nanoparticulate group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages","volume":"10","author":"Corbett","year":"2019","journal-title":"mBio"},{"issue":"6254","key":"10.1016\/j.ebiom.2024.105153_bib37","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A\u00a0stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"issue":"692","key":"10.1016\/j.ebiom.2024.105153_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade4790","article-title":"An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults","volume":"15","author":"Widge","year":"2023","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105153_bib39","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105153_bib40","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105153_bib41","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J\u00a0Virol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105153_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4049\/immunohorizons.1900022","article-title":"Chimeric hemagglutinin-based influenza virus vaccines induce protective stalk-specific humoral immunity and cellular responses in mice","volume":"3","author":"Choi","year":"2019","journal-title":"Immunohorizons"},{"key":"10.1016\/j.ebiom.2024.105153_bib43","article-title":"The whole genome analysis for the first human infection with H10N3 influenza virus in China","author":"Wang","year":"2021","journal-title":"J\u00a0Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01070-22","article-title":"Antigenic landscape analysis of individuals vaccinated with a universal influenza virus vaccine candidate reveals induction of cross-subtype immunity","volume":"97","author":"Meade","year":"2023","journal-title":"J\u00a0Virol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105153_bib45","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1473-3099(08)70232-9","article-title":"Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans","volume":"8","author":"Jennings","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41541-022-00583-w","article-title":"Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination","volume":"7","author":"Aydillo","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"6100","key":"10.1016\/j.ebiom.2024.105153_bib47","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"issue":"40","key":"10.1016\/j.ebiom.2024.105153_bib48","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1073\/pnas.1810927115","article-title":"Influenza hemagglutinin membrane anchor","volume":"115","author":"Benton","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7896","key":"10.1016\/j.ebiom.2024.105153_bib49","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41586-021-04356-8","article-title":"Broadly neutralizing antibodies target a haemagglutinin anchor epitope","volume":"602","author":"Guthmiller","year":"2022","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.ebiom.2024.105153_bib50","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1128\/JVI.01631-14","article-title":"Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein","volume":"88","author":"Chen","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/icb.2012.78","article-title":"Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses","volume":"91","author":"Grant","year":"2013","journal-title":"Immunol Cell Biol"},{"issue":"28","key":"10.1016\/j.ebiom.2024.105153_bib52","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.1007270107","article-title":"Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses","volume":"107","author":"Gras","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2024.105153_bib53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fimmu.2015.00287","article-title":"Boosted influenza-specific T cell responses after H5N1 pandemic live attenuated influenza virus vaccination","volume":"6","author":"Peng","year":"2015","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105153_bib54","first-page":"3478","article-title":"Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals","volume":"118","author":"Lee","year":"2008","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105153_bib55","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","article-title":"Natural T cell-mediated protection against seasonal and pandemic influenza. Results of the flu watch cohort study","volume":"191","author":"Hayward","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105153_bib56","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41590-023-01590-2","article-title":"Baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology","volume":"24","author":"Mettelman","year":"2023","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib57","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001665","article-title":"Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine","volume":"3","author":"Leroux-Roels","year":"2008","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105153_bib60","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.vaccine.2009.12.014","article-title":"Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial","volume":"28","author":"Roman","year":"2010","journal-title":"Vaccine"},{"issue":"9587","key":"10.1016\/j.ebiom.2024.105153_bib61","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105153_bib62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10875-010-9490-6","article-title":"H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses","volume":"31","author":"Moris","year":"2011","journal-title":"J\u00a0Clin Immunol"},{"issue":"23","key":"10.1016\/j.ebiom.2024.105153_bib63","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.vaccine.2019.04.048","article-title":"Safety of AS03-adjuvanted influenza vaccines: a review of the evidence","volume":"37","author":"Cohet","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2024.105153_bib64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.virol.2018.03.013","article-title":"Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin","volume":"518","author":"Isakova-Sivak","year":"2018","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","article-title":"Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A\/Leningrad\/134\/17\/57 (H2N2)","volume":"412","author":"Isakova-Sivak","year":"2011","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105153_bib66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(17)30240-2","article-title":"Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A\/17\/Turkey\/Turkey\/05\/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial","volume":"17","author":"Pitisuttithum","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2024.105153_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-1759(01)00535-X","article-title":"A\u00a0panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays","volume":"260","author":"Currier","year":"2002","journal-title":"J\u00a0Immunol Methods"},{"issue":"41","key":"10.1016\/j.ebiom.2024.105153_bib68","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0707570104","article-title":"Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype","volume":"104","author":"Harari","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2024.105153_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-1759(01)00571-3","article-title":"Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines--a retrospective analysis of three independent field trials","volume":"264","author":"Heldens","year":"2002","journal-title":"J\u00a0Immunol Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/infdis\/jir689","article-title":"Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections","volume":"205","author":"Powell","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib71","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4049\/jimmunol.173.1.673","article-title":"Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine","volume":"173","author":"Kang","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105153_bib72","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/pathogens8040220","article-title":"Peptide epitope hot spots of CD4 T cell recognition within influenza hemagglutinin during the primary response to infection","volume":"8","author":"Knowlden","year":"2019","journal-title":"Pathogens"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105153_bib73","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1128\/jvi.69.12.7497-7506.1995","article-title":"Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection","volume":"69","author":"Gelder","year":"1995","journal-title":"J\u00a0Virol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105153_bib74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/intimm\/dxt005","article-title":"CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination","volume":"25","author":"Yang","year":"2013","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105153_bib75","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib76","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-022-02429-7","article-title":"Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study","volume":"20","author":"Tsang","year":"2022","journal-title":"BMC Med"},{"issue":"24","key":"10.1016\/j.ebiom.2024.105153_bib77","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100439","article-title":"Isolation of clade 2.3.4.4b A(H5N8), a highly pathogenic avian influenza virus, from a worker during an outbreak on a poultry farm, Russia, December 2020","volume":"26","author":"Pyankova","year":"2021","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/irv.12934","article-title":"First human infection of avian influenza A(H5N6) virus reported in Lao People\u2019s Democratic Republic, February-March 2021","volume":"16","author":"Sengkeopraseuth","year":"2022","journal-title":"Influenza Other Respir Viruses"},{"issue":"36","key":"10.1016\/j.ebiom.2024.105153_bib79","doi-asserted-by":"crossref","first-page":"751","DOI":"10.46234\/ccdcw2021.187","article-title":"Five independent cases of human infection with avian influenza H5N6 - sichuan province, China, 2021","volume":"3","author":"Xiao","year":"2021","journal-title":"China CDC Wkly"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105153_bib80","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taad032","article-title":"First case of human infection with highly pathogenic H5 avian influenza a virus in South America: a new zoonotic pandemic threat for 2023?","volume":"30","author":"Bruno","year":"2023","journal-title":"J\u00a0Travel Med"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105153_bib81","first-page":"1053","article-title":"Human flu cases in Cambodia not due to bird flu outbreak viruses","volume":"329","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2024.105153_bib82","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coi.2018.03.019","article-title":"Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus","volume":"53","author":"Sant","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ebiom.2024.105153_bib83","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fimmu.2016.00136","article-title":"New insights into the generation of CD4 memory may shape future vaccine strategies for influenza","volume":"7","author":"Devarajan","year":"2016","journal-title":"Front Immunol"},{"issue":"176","key":"10.1016\/j.ebiom.2024.105153_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105153_bib85","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jiu616","article-title":"Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses","volume":"211","author":"Nayak","year":"2015","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105153_bib86","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00507-21","article-title":"Broadly protective CD8(+) T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine","volume":"95","author":"Zhang","year":"2021","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib87","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.159.2.341","article-title":"Cytotoxic T lymphocyte recognition of the influenza hemagglutinin gene product expressed by DNA-mediated gene transfer","volume":"159","author":"Braciale","year":"1984","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib88","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(84)90187-9","article-title":"Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells","volume":"39","author":"Townsend","year":"1984","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105153_bib89","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization","volume":"80","author":"Gao","year":"2006","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105153_bib90","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10875-011-9632-5","article-title":"Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine","volume":"32","author":"Atsmon","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib91","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21315\/mjms2020.27.2.2","article-title":"Multi-epitope peptide-based and vaccinia-based universal influenza vaccine candidates subjected to clinical trials","volume":"27","author":"Romeli","year":"2020","journal-title":"Malays J Med Sci"},{"issue":"16","key":"10.1016\/j.ebiom.2024.105153_bib92","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.vaccine.2023.03.023","article-title":"Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - a randomized clinical trial","volume":"41","author":"Atmar","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib93","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/s41467-021-23018-x","article-title":"Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients","volume":"12","author":"Nguyen","year":"2021","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105153_bib94","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.humimm.2009.06.004","article-title":"Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4(+) T-cell responses to internal proteins, hemagglutinins, and neuraminidases","volume":"70","author":"Babon","year":"2009","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib95","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/infdis\/jiu662","article-title":"Seasonal influenza can poise hosts for CD4 T-cell immunity to H7N9 avian influenza","volume":"212","author":"Richards","year":"2015","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105153_bib96","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/cmi.2016.20","article-title":"Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB\/c mice","volume":"14","author":"Lu","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105153_bib97","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3390\/v12121461","article-title":"Influenza A H1 and H3 transmembrane domains interact differently with each other and with surrounding membrane lipids","volume":"12","author":"Kubiszewski-Jakubiak","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105153_bib98","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01534-18","article-title":"Why are CD8 T cell epitopes\u00a0of human influenza A virus conserved?","volume":"93","author":"Li","year":"2019","journal-title":"J\u00a0Virol"},{"issue":"22","key":"10.1016\/j.ebiom.2024.105153_bib99","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.1073\/pnas.1105624108","article-title":"Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals","volume":"108","author":"Wu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105153_bib100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41541-019-0153-1","article-title":"Heterologous viral protein interactions within licensed seasonal influenza virus vaccines","volume":"5","author":"Koroleva","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105153_bib101","first-page":"383","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nature reviews"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105153_bib102","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/infdis\/jiaa664","article-title":"Differences in influenza-specific CD4 T-cell mediated immunity following acute infection versus inactivated vaccination in children","volume":"223","author":"Shannon","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105153_bib103","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/vaccines3020293","article-title":"Measuring cellular immunity to influenza: methods of detection, applications and challenges","volume":"3","author":"Coughlan","year":"2015","journal-title":"Vaccines"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T03:52:40Z","timestamp":1732074760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424001889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":103,"alternative-id":["S2352396424001889"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105153","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105153"}}